ANXA6 and breast carcinoma: Paclitaxel not only promoted the production of more exosomes in cancer cells, but also promoted the entry of annexin A6 (ANXA6) protein, a non-glycosylated polypeptide chain into exosomes by increasing calcium levels in cancer cells, which contributed to paclitaxel resistance in breast cancer (131).